Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
13.81T | 13.02T | 11.54T | 9.92T | 9.00T | 8.26T | Gross Profit |
3.67T | 3.33T | 3.14T | 2.70T | 2.44T | 2.33T | EBIT |
1.42T | 1.21T | 1.21T | 1.20T | 971.87B | 845.46B | EBITDA |
2.68T | 2.45T | 2.31T | 2.06T | 1.64T | 1.56T | Net Income Common Stockholders |
1.13T | 970.57B | 1.01T | 882.18B | 1.03T | 582.19B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
2.33T | 2.33T | 1.92T | 2.56T | 4.69T | 3.36T | Total Assets |
34.11T | 34.11T | 32.04T | 30.48T | 26.35T | 23.04T | Total Debt |
4.09T | 4.09T | 4.06T | 3.35T | 2.46T | 1.86T | Net Debt |
2.18T | 2.18T | 2.58T | 1.30T | 669.50B | 346.37B | Total Liabilities |
26.35T | 26.35T | 24.75T | 23.28T | 20.73T | 18.24T | Stockholders Equity |
7.59T | 7.59T | 7.23T | 7.14T | 5.58T | 4.13T |
Cash Flow | Free Cash Flow | ||||
3.18T | 749.27B | -298.94B | 792.55B | 837.91B | 909.98B | Operating Cash Flow |
3.89T | 1.37T | 314.69B | 1.23T | 1.35T | 1.35T | Investing Cash Flow |
-977.10B | -818.89B | -1.05T | -728.78B | -1.78T | -1.35T | Financing Cash Flow |
-722.49B | -210.71B | 84.30B | -336.58B | 666.97B | 65.66B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $2.89T | 31.30 | 30.64% | 0.81% | 15.04% | 12.38% | |
79 Outperform | $147.86B | 19.60 | 13.84% | 0.37% | 1.77% | 18.85% | |
76 Outperform | $3.54T | 37.51 | 144.03% | 0.53% | 2.61% | -2.14% | |
72 Outperform | $197.07B | 35.40 | 5.51% | 0.84% | 3.97% | 89.53% | |
66 Neutral | $33.68B | 32.88 | 14.15% | 0.59% | -2.99% | -0.46% | |
59 Neutral | $22.39B | 11.53 | -18.05% | 2.31% | 5.00% | -25.89% |